David Boerema

Title: The Innovations of David Boerema

Introduction

David Boerema is an accomplished inventor based in Bourbonnais, IL (US). He has made significant contributions to the field of biochemistry, particularly through his work on hemopexin formulations. His innovative approach has led to the development of a stable liquid formulation that has potential applications in medical treatments.

Latest Patents

David Boerema holds a patent for Hemopexin formulations. The present invention relates generally to a stable liquid formulation of purified hemopexin comprising: (a) a hemopexin content of at least 50 mg/mL; (b) at least 15 mM phosphate buffer; (c) a pH from 5.8 to 8; and (d) at least 50 mM sodium chloride. This formulation is designed to enhance the stability and efficacy of hemopexin in various applications.

Career Highlights

David is currently associated with CSL Behring AG, a global leader in biotherapeutics. His work at the company has allowed him to focus on innovative solutions that address critical health challenges. With a patent portfolio that includes 1 patent, he has established himself as a key player in the field.

Collaborations

David has collaborated with notable colleagues such as Thomas Gentinetta and Nathan Brinkman. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

David Boerema's contributions to the field of biochemistry, particularly through his patent on hemopexin formulations, highlight his role as an innovative inventor. His work continues to pave the way for advancements in medical treatments and biotherapeutics.